← Evidence map

ArticleClinical pharmacokinetics2015

Author's Reply to Srinivas: "Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection".

Florence NamourPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2015

2016

2017

2018

2019

2020

2021

2022

this papercites it

Author's Reply to Srinivas: "Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection". | OpenQuestion